Prescription

MRD / Regn No.

: 20260000286

Date

: 01/07/2026

Patient Name

: Mohammad Azad

Age & Gender

: 54 Yrs. / Male

Contact No.

: 6001990069

UHID

:

Ht / Wt / BMI

:

BP S / BP D

:

Allergies

: NKA

Referred By

:

Subjective	:	TYPE 2 DM FOR 6 YEARS,UNABLE TO TOLERATE PROTEIN INTAKE
Objective	:	NONE
Analysis	:	TYPE 2 DM,ANEMIA,DYSLIPIDEMIA,A2G1 DKD,DISTAL SENSORY NEUROPATHY
Plan	:	INCREASE SEMALIX TO 0.5 MG,SEE ME IN 1 MONTH
Salient Investigations	:	FASTING PLASMA GLUCOSE (FPG): 156 mg/dL \| POST PRANDIAL GLUCOSE (2HPP): 194 mg/dL

S#	Generic (Trade) Name	Route	Dosage	Usage	Duration
1	INJECTION DEGLUDEC / ASPART (INJ U100) 70/30 RYZODEG Medicine For DIABETES	SQ	0-16-0 UNITS	BEFORE FOOD	TILL NEXT VISIT
	MAY CAUSE HYPOGLYCEMIA

2	SGLT2I EMPAGLIFLOZIN 10 MG JARDIANCE Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION	PO	1-0-0	BEFORE FOOD	TILL NEXT VISIT
	MAY CAUSE GENITOURINARY INFECTIONS

3	TELMISARTAN 40 MG ERITEL 40 MG		0-0-1	AT BEDTIME	TILL NEXT VISIT
	MAY CAUSE HIGH POTASSIUM

4	ROSUVASTATIN 10 MG ROSEDAY 10 MG Medicine For CHOLESTEROL	PO	0-0-1	AT BEDTIME	TILL NEXT VISIT
	MAY CAUSE FATIGUE AND MUSCLE PAIN

5	INJECTION SEMAGLUTIDE 0.5 MG SEMALIX 0.5 Medicine For DIABETES OBESITY HEART KIDNEY PROTECTION	SQ	EVERY WEEK	AS DIRECTED NO RELATION TO FOOD	TILL NEXT VISIT
	MAY CAUSE NAUSEA CONSTIPATION OR VISUAL DISTURBANCE

Refill : 0 / Substitution:

Education

:

Next Visit

: 31/Jul/2026

Tests Suggested For Next Visit

: FBS 2HPP SMBG HBA1C